Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01322841 · ClinicalTrials.gov registry record · NA
Universal Screening for Tuberculosis and Anemia With the CHICA System
A NA study, sponsored by Indiana University.
- Completed
- Registry status
- NA
- Development phase
- 2,239
- Enrollment target
NCT01322841: Completed NA study, sponsored by Indiana University.
NCT01322841 is a NA study that has completed, run by Indiana University. The registered enrollment target is 2,239 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (59% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01322841, a NA study, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,239 participants
- Enrollment target
Study Summary
The CHICA system is a clinical decision support system that uses adaptive turnaround documents to provide point-of-care information to clinicians. The investigators will be studying whether it can help in the diagnosis and treatment of tuberculosis and iron deficiency anemia.
Interventions
- OTHER CHICA Placebo
- OTHER CHICA Diagnosis Module
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,239 participants |
| Start Date | 2007-10 |
| Est. Completion | 2010-09 |
| Phase | NA |
What the finished NCT01322841 record still lists
NCT01322841 is an interventional study that assigns participants to a tested intervention. Its 2,239 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (59% higher).
The record links to 0 conditions, and to 2 interventions - of which CHICA Placebo is the first listed.
NCT01322841 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01322841 about?
NCT01322841 is a clinical study titled "Universal Screening for Tuberculosis and Anemia With the CHICA System". The CHICA system is a clinical decision support system that uses adaptive turnaround documents to provide point-of-care information to clinicians. The investigators will be studying whether it can help in the diagnosis and treatment of tuberculosis and iron deficiency anemia.
What is the current status of trial NCT01322841?
This trial is currently completed. It is a NA study. The enrollment target is 2,239 participants. The study started on 2007-10. Estimated completion is 2010-09.
What interventions are being tested in trial NCT01322841?
The interventions under investigation include: CHICA Placebo (OTHER), CHICA Diagnosis Module (OTHER).
Who is sponsoring clinical trial NCT01322841?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01322841's enrollment target sits among peer trials
2,239 48th of 2000 higher than 1,953 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06939803 · 2,236 participants · NA
AI-driven Clinical Decision Support to Reduce Hospital-Acquired Venous Thromboembolism: Study Protocol for the VTE-AI Randomized Trial.
- NCT06831929 · 2,232 participants · NA
HPV Ends Here: Increasing Uptake of the HPV Vaccine
- NCT04889872 · 2,250 participants · NA
PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR
- NCT06805513 · 2,250 participants · Phase 3
Actual Use Trial of Tadalafil 5 mg
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia